J Clin Oncol 21:16371647 Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
To minimize them, doctors typically start with a low dose and gradually increase it over time
In critically-ill patients, supplements improved nutritional status indicators, which have a key role in prognosis of diseases (64) and adjunctive use improved symptoms of autism spectrum disorder in children and adolescents (65)
Available at our Lincoln Park clinic or shipped anywhere in Illinois via telehealth